JPMIA
J.P. Marvel Investment Advisors Portfolio holdings
AUM
$621M
This Quarter Return
+9.04%
1 Year Return
+21%
3 Year Return
+119.08%
5 Year Return
+235.08%
10 Year Return
–
AUM
$443M
AUM Growth
+$443M
(+4%)
Cap. Flow
-$1.92M
Cap. Flow
% of AUM
-0.43%
Top 10 Holdings %
Top 10 Hldgs %
44.7%
Holding
72
New
2
Increased
2
Reduced
27
Closed
1
Top Buys
| 1 |
GE Aerospace
GE
|
$2.32M |
| 2 |
Advanced Micro Devices
AMD
|
$1.88M |
| 3 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
$36.3K |
| 4 |
Charles River Laboratories
CRL
|
$20.2K |
Top Sells
| 1 |
CVS Health
CVS
|
$4.54M |
| 2 |
Apple
AAPL
|
$315K |
| 3 |
Eli Lilly
LLY
|
$252K |
| 4 |
Duke Energy
DUK
|
$200K |
| 5 |
Deere & Co
DE
|
$178K |
Sector Composition
| 1 | Healthcare | 31.61% |
| 2 | Technology | 26.95% |
| 3 | Financials | 12.71% |
| 4 | Industrials | 7.04% |
| 5 | Communication Services | 5.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Apple
AAPL
$3.45T
| $34.9M | 7.87% |
211,521
-1,912
| -0.9% | -$315K |
|
2
NVIDIA
NVDA
$4.24T
| $25.2M | 5.67% |
90,560
-50
| -0.1% | -$13.9K |
|
3
Thermo Fisher Scientific
TMO
$186B
| $22.7M | 5.12% |
39,418
-151
| -0.4% | -$87K |
|
4
Alphabet (Google) Class A
GOOGL
$2.57T
| $21.4M | 4.83% |
206,460
| – | – |
|
|
5
Eli Lilly
LLY
$657B
| $19.4M | 4.37% |
56,440
-733
| -1% | -$252K |
|
6
Morgan Stanley
MS
$240B
| $18.2M | 4.1% |
206,866
-214
| -0.1% | -$18.8K |
|
7
JPMorgan Chase
JPM
$829B
| $14.5M | 3.28% |
111,595
-81
| -0.1% | -$10.6K |
|
8
Visa
V
$683B
| $14.4M | 3.25% |
63,922
-5
| -0% | -$1.13K |
|
9
Amazon
AMZN
$2.44T
| $13.9M | 3.12% |
134,140
| – | – |
|
10
AbbVie
ABBV
$372B
| $13.7M | 3.09% |
85,890
| – | – |
|
11
Microsoft
MSFT
$3.77T
| $13M | 2.92% |
44,983
| – | – |
|
12
Bristol-Myers Squibb
BMY
$96B
| $12.4M | 2.8% |
179,291
-90
| -0.1% | -$6.24K |
|
|
13
Deere & Co
DE
$129B
| $11.5M | 2.59% |
27,836
-432
| -2% | -$178K |
|
14
Johnson & Johnson
JNJ
$427B
| $10.5M | 2.37% |
67,829
-605
| -0.9% | -$93.8K |
|
15
Cisco
CSCO
$274B
| $9.8M | 2.21% |
187,448
| – | – |
|
16
Corning
GLW
$57.4B
| $9.09M | 2.05% |
257,780
| – | – |
|
17
Pfizer
PFE
$141B
| $9.03M | 2.04% |
221,248
-219
| -0.1% | -$8.94K |
|
18
Lam Research
LRCX
$127B
| $8.91M | 2.01% |
16,812
-22
| -0.1% | -$11.7K |
|
19
EOG Resources
EOG
$68.2B
| $8.3M | 1.87% |
72,410
-710
| -1% | -$81.4K |
|
20
Danaher
DHR
$147B
| $8.06M | 1.82% |
31,997
| – | – |
|
21
Bank of America
BAC
$376B
| $7.97M | 1.8% |
278,802
| – | – |
|
|
22
Charles River Laboratories
CRL
$8.04B
| $7.35M | 1.66% |
36,422
+100
| +0.3% | +$20.2K |
|
23
Abbott
ABT
$231B
| $7.14M | 1.61% |
70,548
| – | – |
|
24
Moderna
MRNA
$9.37B
| $6.99M | 1.58% |
45,527
-1,048
| -2% | -$161K |
|
25
Akamai
AKAM
$11.3B
| $6.94M | 1.57% |
88,681
-290
| -0.3% | -$22.7K |
|